TY - JOUR
T1 - Analysis of Hepatic Lipid Metabolism and Immune Function During the Development of Collagen-Induced Arthritis
AU - Shi, Yingjie
AU - Shu, Jun
AU - Ning, Zhangchi
AU - Fan, Dancai
AU - Shu, Haiyang
AU - Zhao, Hanxiao
AU - Li, Li
AU - Zhao, Ning
AU - Lu, Cheng
AU - Lu, Aiping
AU - He, Xiaojuan
N1 - Funding Information:
This research was supported by the Fundamental Research Funds for the Central Public Welfare Research Institutes (Z0736) and the National Key R&D Program of China (2018YFC1705205).
Publisher Copyright:
© 2022 Shi, Shu, Ning, Fan, Shu, Zhao, Li, Zhao, Lu, Lu and He.
PY - 2022/6/16
Y1 - 2022/6/16
N2 - The liver is essential for metabolic and immune functions and has been linked to systemic inflammatory diseases. However, the role of the liver is still elusive during the development of rheumatoid arthritis (RA), although there have been indeed some reports. We used label-free quantitative proteomics and experimental verification in this study to reveal the hepatic lipid metabolism and immune function during collagen-induced arthritis (CIA) development. The proteomics results revealed that the role of the liver differs in different phases of CIA rats. In terms of specific performance, hepatic lipid metabolism, which is primarily concerned with cholesterol, triacylglycerol, and phospholipid, was significantly influenced in the CIA induction phase, whereas the immune function, which includes binding of granulocytes, adhesion of immune cells, etc., was affected considerably at the peak phase of CIA rats compared to normal rats. Finally, the hepatic dynamic changes in CIA rats were further confirmed using targeted metabolomics and ELISA. We found that most fatty acids of the liver in the CIA induction phase were significantly decreased, and proteins related to complement activation and migration or adhesion of immune cells including C3, MMP-8, CTSZ, and S100A9 were significantly increased in the liver of CIA rats in the peak phase. Our findings indicated that the lipid metabolism and immune function of the liver were influenced in CIA rats. Thus, the conditions of the liver during RA development should be considered in therapeutic and nutritional interventions.
AB - The liver is essential for metabolic and immune functions and has been linked to systemic inflammatory diseases. However, the role of the liver is still elusive during the development of rheumatoid arthritis (RA), although there have been indeed some reports. We used label-free quantitative proteomics and experimental verification in this study to reveal the hepatic lipid metabolism and immune function during collagen-induced arthritis (CIA) development. The proteomics results revealed that the role of the liver differs in different phases of CIA rats. In terms of specific performance, hepatic lipid metabolism, which is primarily concerned with cholesterol, triacylglycerol, and phospholipid, was significantly influenced in the CIA induction phase, whereas the immune function, which includes binding of granulocytes, adhesion of immune cells, etc., was affected considerably at the peak phase of CIA rats compared to normal rats. Finally, the hepatic dynamic changes in CIA rats were further confirmed using targeted metabolomics and ELISA. We found that most fatty acids of the liver in the CIA induction phase were significantly decreased, and proteins related to complement activation and migration or adhesion of immune cells including C3, MMP-8, CTSZ, and S100A9 were significantly increased in the liver of CIA rats in the peak phase. Our findings indicated that the lipid metabolism and immune function of the liver were influenced in CIA rats. Thus, the conditions of the liver during RA development should be considered in therapeutic and nutritional interventions.
KW - immune function
KW - lipid metabolism
KW - liver
KW - proteomics
KW - rheumatoid arthritis
UR - http://www.scopus.com/inward/record.url?scp=85133286443&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2022.901697
DO - 10.3389/fimmu.2022.901697
M3 - Journal article
C2 - 35784282
AN - SCOPUS:85133286443
SN - 1664-3224
VL - 13
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 901697
ER -